Craig-Hallum upgrades Axcelis to Buy with estimate cuts seen being over

As previously reported, Craig-Hallum analyst Christian Schwab upgraded Axcelis to Buy from Hold with an unchanged price target of $130 following the company’s Q1 report. The firm had downgraded shares nine months ago as it had preferred to look for a more attractive entry point, but now it believes estimate cuts are over with, leaving shares “much better positioned.”